Results of a single-center, single-dose, randomized-sequence, open-label, two-way crossover bioequivalence study of two formulations of valsartan 160-mg tablets in healthy volunteers under fasting conditions

✍ Scribed by Ana Cristina Franco Spínola; Susana Almeida; Augusto Filipe; Rita Neves; Fethi Trabelsi; Anna Farré

• Book ID: 113544039
• Publisher: Elsevier Science
• Year: 2009
• Tongue: English
• Weight: 144 KB
• Volume: 31
• Category: Article
• ISSN: 0149-2918
• DOI: 10.1016/j.clinthera.2009.09.002